Elidel and Bleeding into the skin - a phase IV clinical study of FDA data

Summary:

Bleeding into the skin is reported as a side effect among people who take Elidel (pimecrolimus), especially for people who are male, 0-1 old, have been taking the drug for 1 - 2 years also take Triamcinolone, and have Rashes.

The phase IV clinical study analyzes which people have Bleeding into the skin when taking Elidel. It is created by eHealthMe based on reports of 5,143 people who have side effects when taking Elidel from the FDA, and is updated regularly.

What is Elidel?

Elidel has active ingredients of pimecrolimus. It is often used in eczema. eHealthMe is studying from 5,201 Elidel users. Check the latest studies of Elidel.

What is Bleeding into the skin?

Bleeding into the skin is found to be associated with 937 drugs and 1,908 conditions by eHealthMe. Check the latest studies of Bleeding into the skin.

On May, 08, 2026

5,143 people reported to have side effects when taking Elidel.
Among them, 16 people (0.31%) have Bleeding into the skin.

Could Elidel cause Bleeding into the skin?

Among these 16 people:

How long have people been on Elidel when they have Bleeding into the skin? *

What is the gender of people who have Bleeding into the skin when taking Elidel? *

female: 50 %
male: 50 %

What is the age of people who have Bleeding into the skin when taking Elidel? *

What are other drugs people take besides Elidel? *

Mercaptopurine: 9 people, 56.25%
Bactrim: 9 people, 56.25%
Triamcinolone: 9 people, 56.25%
Methotrexate: 7 people, 43.75%
Ceftazidime: 7 people, 43.75%
Chlorhexidine Gluconate: 7 people, 43.75%
Famotidine: 7 people, 43.75%
Hydrocortisone: 7 people, 43.75%
Amoxicillin: 7 people, 43.75%
Vancomycin: 7 people, 43.75%

What are other side effects people have besides Bleeding into the skin? *

Fever: 13 people, 81.25%
Thrombocytopenia (decrease of platelets in blood): 11 people, 68.75%
Respiratory Syncytial Virus Infection (viral disease of respiratory system): 10 people, 62.50%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 9 people, 56.25%
Chest Pain: 7 people, 43.75%
Otitis Media (inflammation of the middle ear): 7 people, 43.75%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 7 people, 43.75%
Limb Injury: 7 people, 43.75%
Rashes (redness): 7 people, 43.75%
Molluscum Contagiosum (a viral infection of the skin or occasionally of the mucous membranes): 7 people, 43.75%

What are the existing conditions these people have? *

Rashes (redness): 7 people, 43.75%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 5 people, 31.25%
Hordeolum (small collection of pus (abscess) on the eyelid): 2 people, 12.50%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Elidel and have Bleeding into the skin?

- Check whether Bleeding into the skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elidel:

Elidel (5,201 reports)

Browse all side effects of Elidel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bleeding into the skin:

Bleeding into the skin (937 drugs)

Browse all the conditions that are associated with Bleeding into the skin:

Bleeding into the skin (1,908 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pimecrolimus (the active ingredients of Elidel) and Elidel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.